Reckitt Benckiser Pharmaceuticals Inc. Receives FDA Approval for Suboxone (buprenorphine and naloxone) Sublingual Film C-III

September 5, 2011

Richmond, VA (31st August 2010) – Reckitt Benckiser Pharmaceuticals Inc. today announces that it has received approval from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) to manufacture and market Suboxone… (Source: Drugs.com – New Drug Approvals)

Read the full article →

MonoSol Rx Announces Reckitt Benckiser FDA Approval Of Suboxone® Sublingual Film For Treatment Of Opioid Dependence

September 5, 2011

MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in film pharmaceutical products, today announced that its partner, Reckitt Benckiser Pharmaceuticals Inc., a wholly-owned subsidiary of Reckitt Benckiser Group plc (LSE: RB), has received approval from the U.S. Food and Drug Administration (FDA) to market Suboxone® (buprenorphine HCl/naloxone HCl dihydrate) sublingual […]

Read the full article →

Opioid Dependence Drug Gets Okay for New Delivery Mode

September 5, 2011

WASHINGTON (MedPage Today) — The FDA has approved a new sublingual film formulation of the opioid dependence treatment combination buprenorphrine/naloxone (Suboxone). (Source: MedPage Today Public Health)

Read the full article →

FDA Approves Sublingual Film Formulation of Buprenorphine/Naloxone

September 5, 2011

Previously only available in sublingual tablet form, buprenorphine/naloxone in the form of a sublingual film will become available in starting in October 2010. Medscape Medical News (Source: Medscape Pharmacist Headlines) MedWorm Sponsor Message: Find out how you can get your message posted here and on over 100,000 other medical web pages in just a couple […]

Read the full article →

Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: a series of 27 cases.

September 5, 2011

CONCLUSIONS: Although codeine can be considered a relatively weak opioid analgesic, it is nevertheless addictive, and the significant morbidity and specific patient characteristics associated with overuse of codeine-ibuprofen analgesics support further awareness, investigation and monitoring of OTC codeine-ibuprofen analgesic use. PMID: 20819050 [PubMed – in process] (Source: Med J Aust)

Read the full article →

SUBOXONE (Buprenorphine And Naloxone) Film, Soluble [Reckitt Benckiser Pharmaceuticals Inc.]

September 5, 2011

Updated Date: Sep 20, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

Read the full article →

Suboxone (Buprenorphine HCl and naloxone HCl) – updated on RxList

September 5, 2011

Suboxone (Buprenorphine HCl and naloxone HCl) drug description – FDA approved labeling for prescription drugs and medications at RxList (Source: RxList – New and Updated Drug Monographs)

Read the full article →

Buprenorphine Implants for Treatment of Opioid Dependence: A Randomized Controlled Trial [Original Contribution]

September 5, 2011

Conclusion  Among persons with opioid dependence, the use of buprenorphine implants compared with placebo resulted in less opioid use over 16 weeks as assessed by urine samples. Trial Registration  clinicaltrials.gov Identifier: NCT00447564 (Source: JAMA)

Read the full article →

Implantable Agent Cuts Positive Urine Screens (CME/CE)

September 5, 2011

(MedPage Today) — An implantable form of the opioid addiction drug buprenorphine (Subutex, Suboxone) kept more patients testing “clean” for four months compared with placebo, researchers reported. (Source: MedPage Today Psychiatry) MedWorm Sponsor Message: Find out how you can get your message posted here and on over 100,000 other medical web pages in just a […]

Read the full article →

Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment.

September 5, 2011

Authors: Maremmani I, Gerra G Maintenance therapy with methadone or buprenorphine-based regimens reduces opioid dependence and associated harms. The perception that methadone is more effective than buprenorphine for maintenance treatment has been based on low buprenorphine doses and excessively slow induction regimens used in early buprenorphine trials. Subsequent studies show that the efficacy of buprenorphine […]

Read the full article →

← Previous Entries

Next Entries →